survodutide (BI 456906) - Boehringer Ingelheim
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity (clinicaltrials.gov) - Sep 10, 2026 - P1 | N=44 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting 
Enrollment open • Genetic Disorders • Obesity
http://clinicaltrials.gov/ct2/show/NCT07768813
 
Sep 10, 2026
 
Prev Next